Mark Christopher Bradley

ALMS

Mark Christopher Bradley serves as officer: Chief Development Officer at Alumis Inc. (ALMS). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

1 trades

$67.8K

Net Position

Net Seller

$67.8K

Companies Traded

ALMS

Active Period

Aug 2026

1 total trades

Most Recent

Sell ALMS

Aug 5, 2026 · $67.8K

Mark Christopher Bradley's Insider Trading at Alumis Inc. (ALMS)

Buys

0 · $0.00

Sells

1 · $67.8K

Total Shares Bought

Total Shares Sold

2,572

ALMS Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Aug 5, 2026	Sell	2,572	$26.37	$67.8K	48,533

Related Insiders

AKKARAJU SRINIVAS

Director

ALMSSell · Sep 9, 2026

Jorn Drappa

officer: Chief Medical Officer

ALMSSell · Aug 5, 2026

David M Goldstein

officer: Chief Scientific Officer

ALMSSell · Aug 5, 2026

Roy C. Hardiman

officer: Chief Business & Strategy Ofcr

ALMSSell · Aug 5, 2026

Sanam Pangali

officer: Chief Legal Officer

ALMSSell · Aug 5, 2026

John R. Schroer

officer: Chief Financial Officer

ALMSSell · Aug 5, 2026

Foresite Labs, LLC

10 percent owner

ALMSBuy · Jan 12, 2026

Foresite Capital Management VI LLC

10 percent owner

ALMSBuy · Jan 12, 2026

Explore More Insider Trading Data

ALMS Insider Trading Activity

View all insider trades at Alumis Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity